All Presentations

Using Health Technology Assessment to Assist Government Decision-Making Regarding Novel Interventions in South Africa: Applications from PrEP to COVID-19 Therapeutics

Context National Health Insurance (NHI) aims to provide universal healthcare coverage for all Significant step towards achieving equitable healthcare access Health Technology Assessment (HTA) provides critical evidence to support policy and funding decisions Multidisciplinary process to assess the value and impact of health technologies Especially important in the context of NHI Recently developed HTA framework and methods guide aims to assist analysts in preparation for 

Understanding the Costs and Resource Requirements for Offering a Smoking Cessation Programme at Primary Health Care Facilities in South Africa

Background Tobacco dependence associated with an increased risk for developing lung cancer. The health benefits of quitting smoking have been well-established. In South Africa, smoking cessation support is mainly through private support. How much it will cost to make a smoking cessation service available publicly? Guidelines for the continuum of care in lung cancer have been 

Evaluating the effect of dynamic changes in risk profile on subsequent interruption in HIV treatment: A threshold approach to risk triaging

The HIV care journey Continuity of HIV care is critical yet challenging, especially in the early treatment period RETAIN6: Models of care for the first six months of HIV treatment Optimize service delivery during the “early treatment” period About half of initiating clients experience an interruption in treatment during the first 12 months on 

Preferences for services in a patient’s first six months on antiretroviral therapy for HIV: The PREFER study

Background In sub-Saharan Africa, interruption in HIV treatment is most common in the first six months after starting ART In SA, 26% were lost to follow up by 6 months (Aurum, 2020) Likely reasons for high attrition in first six months include: Better patient condition (higher CD4 counts) at initiation, reducing commitment to lifelong adherence Logistical barriers to accessing care (time, travel costs, etc.) High and increasing proportion of re-initiators, who have already 

Integration of tuberculosis and mental health care services

Summary The physical, psychological, social and economic burden of TB on the patient before, during and even after TB treatment is significant.  Routine screening and effective management of comorbid depression and anxiety in TB patients should be incorporated into TB programmes using a more holistic approach to TB care. Integrating psycho-socio-economic support interventions can add significant value to TB control through improvements in treatment success rates and reductions in 

Ideal Clinic Realisation and Maintenance program in South Africa.

To address the historical inequalities in the quality of primary health care services and to lay a strong foundation for the implementation of the National Health Insurance (NHI), the Ideal Clinic Realisation and Maintenance  (ICRM) programme was established in 2015. The ICRM program implementation will hopefully improve the South African health system's performance in managing priority infectious diseases (e.g HIV, TB) and non-communicable diseases (e.g diabetes, hypertension). This health 

Combating TB in South Africa

South Africa is experiencing a dual TB/HIV epidemic. Approximately 360 000 South African had TB in 2019. TB is the leading cause of death among people living with HIV. Of the 58 000 people who died from TB in South Africa, 36 000 were diagnosed with HIV. With the launch of the 2017-2022 National Strategic PLan (NSP), the South African government aims to eliminate TB by 2030. As an organisation working at the intersection of health economics and epidemiology, HE²RO aims to work towards 

Thusa-Thuso: Helping You Help

In September 2016, South Africa began the implementation of WHO’s Universal Test and Treat (UTT) policy in hopes of reaching the 90-90-90 targets by 2020 and reducing HIV- related morbidity, mortality and HIV transmission rates.1,3 Although 3.8 million HIV positive patients are currently receiving antiretroviral therapy (ART) (March 2017), over 2 million patients will have to be enrolled on HIV treatment for South Africa to reach the 90% on ART target.1,4 While the Department of Health 

Correspondence: First International Post-Tuberculosis Symposium

The First International Post-Tuberculosis Symposium was held in Stellenbosch, South Africa, on July 22–23, 2019, to discuss priorities and gaps that need to be addressed in order to provide guidance in this neglected area. The symposium involved 68 delegates across 12 disciplines from five continents, representing more than 27 institutions. Historically, inconsistency and lack of consensus in nomenclature and terminology have hampered work in this field. Using the Delphi process, the 

Satellite Session at SA AIDS: South Africa’s Investment Case: What are the country’s “best buys” for HIV and TB?

HE2RO staff Dr Gesine Meyer-Rath and Calvin Chiu were instrumental in the analysis behind the South African HIV and TB Investment Case for which results have just been finalized. The Investment Case is an analytical exercise by the South African Department of Health, SANAC and UNAIDS to establish the most cost effective mix of interventions against both HIV and TB over the next twenty years. Results for Phase 1 of the Investment Case were discussed in a satellite session, during the 7th South